Move over Viagra — call it the pink pill for women.
The FDA has approves female sex pill, the first prescription drug to boost sexual desire in women, but there are some restrictions.
It’s a milestone long sought by the pharmaceutical industry, but safety restrictions on the daily pill, called Addyi, mean it will probably never achieve the blockbuster sales of men’s impotence drugs like Viagra, which have generated billions.
There’s a bold warning on the new drug.
In combo with common medications, including drugs used to treat yeast infections or with alcohol – the drug can cause dangerously low blood pressure and fainting.
The FDA previously rejected the drug twice due to lackluster benefits and worrisome side effects.
But women’s groups have long been on the lookout for a drug to treat low libido.
The FDA approval marks an unusual turnaround for the agency.
